J&J's Baby, Beauty Sectors Boost Consumer Health Sales Rebound
This article was originally published in The Rose Sheet
Johnson’s baby product sales picked up in the third quarter after a rough start as its baby care division sales up 20% in the US to $120m. US consumer health sales grew 6.6% to $1.37bn, also helped by total worldwide beauty sales increasing 6.5% to $1.08bn.
You may also be interested in...
Johnson & Johnson intends to buy out Japan-based Ci:z Holdings for north of $2bn, which would give it full ownership of the firm’s dermocosmetic brand portfolio, including Dr.Ci:Labo, a standout performer for J&J’s beauty and larger consumer business in 2018.
The overhaul in line with “modern parents’ preferences” could be what’s needed to rouse the sleepy brand and spur Consumer business growth.
Baby care products sales were a drag on J&J's consumer sector, falling at a reported 7.7% to $456m. US sales particularly were off, down reported21.2% to $89m, and international results were off 3.7% to $367m. Worldwide beauty sales were up a reported 3.1% to $1.11bn, but US sales were down 1.8% to $637m.